Skip to content

Medical-device intelligence

JBF: Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening

FDA product code JBF: Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JBF
FDA device name
Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening
Device class
2
Regulation number
864.7360
Medical specialty
Hematology
Review panel
HE

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

5 clearance records and 1 recall records in the covered releases, across 5 source company names and 1 product codes. Dated history runs from Jun 29, 1995 to Sep 14, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

6 matching records
Device / recordCompany in FDA recordSourceSource date
FINDER G6PDK201049 · JBFBaebies, Inc.510(k)Sep 14, 2022FDA decision date
BinaxNOW G6PD TestK161364 · JBFAlere Scarborough, Inc.510(k)Jun 17, 2016FDA decision date
Pointe Scientific G6PD Controls Kit configuration: 6 x 0.5 ml (2 vials each of Level 1, Level 2 and Level 3). Also sold as individual vials Bot…Z-2487-2015 · JBFPointe Scientific, Inc.RecallAug 31, 2015FDA classification date
BINAXNOW G6PD TESTK080003 · JBFBinax, Inc.510(k)Oct 23, 2008FDA decision date
G6PDH, GLUCOSE-6-PHOSHATE DEHYDROGENASEK024006 · JBFPointe Scientific, Inc.,510(k)Mar 31, 2003FDA decision date
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY SCREENING TEST KIT NO. 202-AK933934 · JBFSigma Diagnostics, Inc.510(k)Jun 29, 1995FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗